VXRT
Vaxart, Inc.
+0.01 (+1.06%)0.48USD44.8K成交股數115M市值3.0本益比(近四季)0.5股價營收比-31.6%營收年增(近四季)2026-11-12下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 7K · 0 |
| 近 180 天 淨額 | 7K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-16 | 07-20 | Finney Kevin | Director | A 獲配股票 | 39.4K | – | – | 244K | SEC |
| 2026-07-16 | 07-17 | HERON ELAINE J | Director | A 獲配股票 | 39.4K | – | – | 136K | SEC |
| 2026-07-16 | 07-17 | Watson W. Mark | Director | A 獲配股票 | 39.4K | – | – | 174K | SEC |
| 2026-07-16 | 07-17 | BREITMEYER JAMES B | Director | A 獲配股票 | 8.3K | – | – | 87.1K | SEC |
| 2026-07-16 | 07-17 | Wheadon David E. | Director | A 獲配股票 | 39.4K | – | – | 86.2K | SEC |
| 2026-05-22 | 05-26 | Watson W. Mark | Director | P 公開市場買進 | 10.0K | 0.65 | 7K | 134K | SEC |
| 2026-05-19 | 05-21 | Grasman Jeroen Nicolaas | Chief Financial Officer | F 繳稅扣股 | 31.4K | 0.61 | 19K | 546K | SEC |
| 2026-04-23 | 05-01 | BREITMEYER JAMES B | Director | A 獲配股票 | 78.8K | – | – | 78.8K | SEC |
| 2026-03-28 | 03-31 | Tucker Sean | SVP, Chief Scientific Officer | F 繳稅扣股 | 3.9K | 0.65 | 3K | 883K | SEC |
| 2026-03-28 | 03-31 | Cummings James F. | Chief Medical Officer | F 繳稅扣股 | 3.3K | 0.65 | 2K | 924K | SEC |
| 2026-03-24 | 03-26 | Lo Steven | President, Chief Exec Officer | F 繳稅扣股 | 126K | 0.69 | 87K | 2.5M | SEC |
| 2026-03-24 | 03-26 | Tucker Sean | SVP, Chief Scientific Officer | F 繳稅扣股 | 36.4K | 0.69 | 25K | 887K | SEC |
| 2026-03-24 | 03-26 | Cummings James F. | Chief Medical Officer | F 繳稅扣股 | 30.6K | 0.69 | 21K | 927K | SEC |
| 2026-03-24 | 03-26 | Berg Edward B | SVP, General Counsel | F 繳稅扣股 | 36.4K | 0.69 | 25K | 755K | SEC |
| 2026-03-18 | 03-20 | Tucker Sean | SVP, Chief Scientific Officer | F 繳稅扣股 | 8.1K | 0.63 | 5K | 923K | SEC |
| 2026-03-18 | 03-20 | Berg Edward B | SVP, General Counsel | F 繳稅扣股 | 8.1K | 0.63 | 5K | 792K | SEC |
| 2026-03-18 | 03-20 | Lo Steven | President, Chief Exec Officer | F 繳稅扣股 | 22.4K | 0.63 | 14K | 2.6M | SEC |
| 2026-03-18 | 03-20 | Cummings James F. | Chief Medical Officer | F 繳稅扣股 | 6.8K | 0.63 | 4K | 958K | SEC |
| 2026-03-16 | 03-18 | Berg Edward B | SVP, General Counsel | A 獲配股票 | 115K | – | – | 800K | SEC |
| 2026-03-16 | 03-18 | Tucker Sean | SVP, Chief Scientific Officer | A 獲配股票 | 200K | – | – | 931K | SEC |
| 2026-03-16 | 03-18 | Lo Steven | President, Chief Exec Officer | A 獲配股票 | 847K | – | – | 2.6M | SEC |
| 2026-03-16 | 03-18 | Grasman Jeroen Nicolaas | Chief Financial Officer | A 獲配股票 | 227K | – | – | 577K | SEC |
| 2026-03-16 | 03-18 | Cummings James F. | Chief Medical Officer | A 獲配股票 | 227K | – | – | 965K | SEC |
| 2026-02-02 | 02-05 | Tucker Sean | SVP, Chief Scientific Officer | F 繳稅扣股 | 9.3K | 0.61 | 6K | 731K | SEC |
| 2026-02-02 | 02-05 | Cummings James F. | Chief Medical Officer | F 繳稅扣股 | 8.0K | 0.61 | 5K | 738K | SEC |
| 2026-02-02 | 02-05 | Berg Edward B | SVP, General Counsel | F 繳稅扣股 | 9.3K | 0.61 | 6K | 685K | SEC |
| 2025-12-04 | 12-08 | Lo Steven | President, Chief Exec Officer | F 繳稅扣股 | 54.2K | 0.37 | 20K | 1.8M | SEC |
| 2025-12-04 | 12-08 | Lo Steven | President, Chief Exec Officer | A 獲配股票 | 151K | – | – | 1.8M | SEC |
| 2025-11-17 | 12-05 | Watson W. Mark | Director | P 公開市場買進 | 5.0K | 0.41 | 2K | 124K | SEC |
| 2025-11-17 | 12-05 | Watson W. Mark | Director | P 公開市場買進 | 15.0K | 0.41 | 6K | 119K | SEC |
| 2025-11-17 | 11-21 | HERON ELAINE J | Director | P 公開市場買進 | 16.8K | 0.41 | 7K | 96.6K | SEC |
| 2025-11-17 | 11-21 | HERON ELAINE J | Director | P 公開市場買進 | 23.2K | 0.39 | 9K | 79.8K | SEC |
| 2025-08-15 | 08-19 | Finney Kevin | Director | P 公開市場買進 | 50.0K | 0.37 | 19K | 205K | SEC |
| 2025-08-15 | 08-19 | Finney Kevin | Director | P 公開市場買進 | 50.0K | 0.35 | 18K | 155K | SEC |
| 2025-07-30 | 08-19 | Finney Kevin | Director | P 公開市場買進 | 25.9K | 0.38 | 10K | 105K | SEC |
| 2025-07-29 | 07-31 | Watson W. Mark | Director | P 公開市場買進 | 10.0K | 0.41 | 4K | 104K | SEC |
| 2025-07-28 | 08-19 | Finney Kevin | Director | P 公開市場買進 | 20.0K | 0.40 | 8K | 78.9K | SEC |
| 2025-07-25 | 08-19 | Finney Kevin | Director | P 公開市場買進 | 20.0K | 0.39 | 8K | 58.9K | SEC |
| 2025-07-17 | 08-19 | Finney Kevin | Director | P 公開市場買進 | 794 | 0.38 | 301.72 | 38.9K | SEC |
| 2025-06-13 | 06-16 | Wheadon David E. | Director | A 獲配股票 | 16.0K | – | – | 46.8K | SEC |
| 2025-06-13 | 06-16 | Finney Kevin | Director | A 獲配股票 | 6.1K | – | – | 38.1K | SEC |
| 2025-06-13 | 06-16 | Finney Michael J. | Director | A 獲配股票 | 16.0K | – | – | 703K | SEC |
| 2025-06-13 | 06-16 | Watson W. Mark | Director | A 獲配股票 | 16.0K | – | – | 94.1K | SEC |
| 2025-06-13 | 06-16 | HERON ELAINE J | Director | A 獲配股票 | 16.0K | – | – | 56.6K | SEC |
| 2025-05-19 | 05-20 | Grasman Jeroen Nicolaas | Chief Financial Officer | A 獲配股票 | 350K | – | – | 350K | SEC |
| 2025-05-19 | 05-19 | Lo Steven | President, Chief Exec Officer | P 公開市場買進 | 100K | 0.49 | 49K | 100K | SEC |
| 2025-03-28 | 04-01 | Cummings James F. | Chief Medical Officer | F 繳稅扣股 | 3.3K | 0.42 | 1K | 746K | SEC |
| 2025-03-28 | 04-01 | Tucker Sean | SVP, Chief Scientific Officer | F 繳稅扣股 | 3.9K | 0.42 | 2K | 740K | SEC |
| 2025-03-24 | 03-26 | Lee Phillip E | Chief Financial Officer | A 獲配股票 | 406K | – | – | 632K | SEC |
| 2025-03-24 | 03-26 | Lo Steven | President, Chief Exec Officer | A 獲配股票 | 1.4M | – | – | 1.6M | SEC |
| 2025-03-24 | 03-26 | Cummings James F. | Chief Medical Officer | A 獲配股票 | 406K | – | – | 749K | SEC |
| 2025-03-24 | 03-26 | Berg Edward B | SVP, General Counsel | A 獲配股票 | 406K | – | – | 694K | SEC |
| 2025-03-24 | 03-26 | Tucker Sean | SVP, Chief Scientific Officer | A 獲配股票 | 406K | – | – | 744K | SEC |
| 2025-03-18 | 03-20 | Lee Phillip E | Chief Financial Officer | F 繳稅扣股 | 8.1K | 0.57 | 5K | 226K | SEC |
| 2025-03-18 | 03-20 | Tucker Sean | SVP, Chief Scientific Officer | F 繳稅扣股 | 8.1K | 0.57 | 5K | 338K | SEC |
| 2025-03-18 | 03-20 | Berg Edward B | SVP, General Counsel | F 繳稅扣股 | 8.1K | 0.57 | 5K | 288K | SEC |
| 2025-03-18 | 03-20 | Cummings James F. | Chief Medical Officer | F 繳稅扣股 | 6.8K | 0.57 | 4K | 343K | SEC |
| 2025-03-18 | 03-20 | Lo Steven | President, Chief Exec Officer | F 繳稅扣股 | 22.4K | 0.57 | 13K | 228K | SEC |
| 2025-02-02 | 02-04 | Tucker Sean | SVP, Chief Scientific Officer | F 繳稅扣股 | 9.2K | 0.68 | 6K | 346K | SEC |
| 2025-02-02 | 02-04 | Cummings James F. | Chief Medical Officer | F 繳稅扣股 | 8.0K | 0.68 | 5K | 319K | SEC |
| 2025-02-02 | 02-04 | Berg Edward B | SVP, General Counsel | F 繳稅扣股 | 9.2K | 0.68 | 6K | 261K | SEC |
| 2025-01-28 | 01-29 | Finney Kevin | Director | A 獲配股票 | 32.0K | – | – | 32.0K | SEC |
| 2024-12-15 | 12-17 | Lee Phillip E | Chief Financial Officer | F 繳稅扣股 | 6.1K | 0.59 | 4K | 234K | SEC |
| 2024-06-18 | 06-20 | Watson W. Mark | Director | P 公開市場買進 | 20.0K | 0.68 | 14K | 78.1K | SEC |
| 2024-06-12 | 06-13 | Lee Phillip E | Chief Financial Officer | F 繳稅扣股 | 2.0K | 0.76 | 2K | 240K | SEC |
| 2024-06-11 | 06-12 | Watson W. Mark | Director | A 獲配股票 | 16.0K | – | – | 58.1K | SEC |
| 2024-06-11 | 06-12 | Yedid Robert A. | Director | A 獲配股票 | 16.0K | – | – | 34.5K | SEC |
| 2024-06-11 | 06-12 | Wheadon David E. | Director | A 獲配股票 | 16.0K | – | – | 30.8K | SEC |
| 2024-06-11 | 06-12 | Finney Michael J. | Director | A 獲配股票 | 16.0K | – | – | 687K | SEC |
| 2024-06-11 | 06-12 | HERON ELAINE J | Director | A 獲配股票 | 16.0K | – | – | 40.6K | SEC |
| 2024-03-28 | 04-01 | Cummings James F. | Chief Medical Officer | F 繳稅扣股 | 3.3K | 1.30 | 4K | 327K | SEC |
| 2024-03-28 | 04-01 | Tucker Sean | SVP, Chief Scientific Officer | F 繳稅扣股 | 3.9K | 1.30 | 5K | 356K | SEC |
| 2024-03-18 | 03-20 | Cummings James F. | Chief Medical Officer | A 獲配股票 | 90.0K | – | – | 330K | SEC |
| 2024-03-18 | 03-20 | Berg Edward B | SVP, General Counsel | A 獲配股票 | 90.0K | – | – | 271K | SEC |
| 2024-03-18 | 03-20 | Lo Steven | President, Chief Exec Officer | A 獲配股票 | 250K | – | – | 250K | SEC |
| 2024-03-18 | 03-20 | Lee Phillip E | Chief Financial Officer | A 獲配股票 | 90.0K | – | – | 242K | SEC |
| 2024-03-18 | 03-20 | Tucker Sean | SVP, Chief Scientific Officer | A 獲配股票 | 90.0K | – | – | 420K | SEC |
| 2024-02-02 | 03-20 | Cummings James F. | Chief Medical Officer | F 繳稅扣股 | 8.0K | 1.20 | 10K | 240K | SEC |
| 2024-02-02 | 03-20 | Berg Edward B | SVP, General Counsel | F 繳稅扣股 | 9.2K | 1.20 | 11K | 181K | SEC |
| 2024-02-02 | 03-20 | Tucker Sean | SVP, Chief Scientific Officer | F 繳稅扣股 | 9.2K | 1.20 | 11K | 330K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| Heritage Wealth Advisors | 29.7K | 18K | 不變 | 持平 |
| KINGSWOOD WEALTH ADVISORS, LLC | 10.0K | 6K | 新進 | 新進 |
| Archer Investment Corp | 30 | 18.00 | +15 (+100%) | 加碼 |
| LVM CAPITAL MANAGEMENT LTD/MI | 25.0K | 15.00 | 不變 | 持平 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 4 -1 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 1 / 2 / 1 / 0 |
| 機構合計持股 · 佔流通股 | 64.7K · 0.0% |
| 合計季末市值 | 24K |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 2.3M |
|---|---|
| 與上期比 | -0.9% |
| 佔流通股數 | 0.95% |
| 日均成交量 | 603K |
| 回補天數 | 3.8 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 2.3M | -0.9% | 0.95% | 603K | 3.8 |
| 2026-08-14 | 2.3M | -5.1% | 0.96% | 433K | 5.4 |
| 2026-07-31 | 2.5M | -4.4% | 1.01% | 627K | 3.9 |
| 2026-07-15 | 2.6M | -0.5% | 1.06% | 604K | 4.3 |
| 2026-06-30 | 2.6M | -1.6% | 1.06% | 750K | 3.5 |
| 2026-06-15 | 2.6M | -1.1% | 1.08% | 626K | 4.2 |
| 2026-05-29 | 2.7M | -0.1% | 1.09% | 946K | 2.8 |
| 2026-05-15 | 2.7M | -9.0% | 1.10% | 963K | 2.8 |
| 2026-04-30 | 2.9M | -4.0% | 1.20% | 825K | 3.6 |
| 2026-04-15 | 3.0M | +0.9% | 1.25% | 609K | 5.0 |
| 2026-03-31 | 3.0M | -7.9% | 1.24% | 997K | 3.0 |
| 2026-03-13 | 3.3M | -10.1% | 1.35% | 1.2M | 2.6 |
| 2026-02-27 | 3.6M | -1.8% | 1.50% | 1.2M | 2.9 |
| 2026-02-13 | 3.7M | +1.3% | 1.53% | 673K | 5.5 |
| 2026-01-30 | 3.7M | +1.3% | 1.51% | 1.5M | 2.4 |
| 2026-01-15 | 3.6M | -1.7% | 1.49% | 4.1M | 1.0 |
| 2025-12-31 | 3.7M | -7.5% | 1.51% | 1.1M | 3.2 |
| 2025-12-15 | 4.0M | -24.5% | 1.64% | 1.0M | 3.9 |
| 2025-11-28 | 5.3M | -11.1% | 2.17% | 876K | 6.0 |
| 2025-11-14 | 5.9M | +1.1% | 2.44% | 1.5M | 3.8 |
| 2025-10-31 | 5.9M | -8.1% | 2.41% | 969K | 6.0 |
| 2025-10-15 | 6.4M | -7.4% | 2.62% | 1.1M | 5.7 |
| 2025-09-30 | 6.9M | -0.1% | 2.83% | 1.1M | 6.5 |
| 2025-09-15 | 6.9M | -6.2% | 2.84% | 1.0M | 6.8 |
| 2025-08-29 | 7.3M | -1.6% | 3.03% | 893K | 8.2 |
| 2025-08-15 | 7.5M | -7.3% | 3.07% | 1.1M | 7.1 |